Who has invested in GondolaBio?

Viking Global Investors, Sequoia Capital, Patient Square Capital are named among the investors backing GondolaBio.

GondolaBio Funding: $300M Raised, Seed (2024)

GondolaBio funding overview

GondolaBio is based in Palo Alto, California. GondolaBio has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Seed announced in August 2024. The round record for GondolaBio runs through 2024; nothing later has been disclosed. Investors on record include Viking Global Investors, Sequoia Capital, Patient Square Capital. 3 distinct backers are named across the disclosed rounds.

GondolaBio at a glance

Total raised: $300M
Latest round: Seed
Latest round date: August 2024
Headquarters: Palo Alto, California
Notable investors: Viking Global Investors, Sequoia Capital, Patient Square Capital

Frequently asked about GondolaBio funding

How much has GondolaBio raised?: GondolaBio has raised $300M in total disclosed funding across the rounds on record.
Who has invested in GondolaBio?: Viking Global Investors, Sequoia Capital, Patient Square Capital are named among the investors backing GondolaBio.
What was the latest GondolaBio funding round?: The most recent disclosed round is a Seed, announced in August 2024.
Where is GondolaBio based?: GondolaBio is based in Palo Alto, California.
When did GondolaBio last raise?: The last disclosed GondolaBio round closed in August 2024 at Seed.

We update the GondolaBio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Palo Alto and their backers are listed below.

GondolaBio Funding: $300M Raised, Seed (2024)

GondolaBio funding overview

GondolaBio at a glance

Frequently asked about GondolaBio funding

Companies related to GondolaBio (36)

Browse related funding lists (8)